49.8 F
New York
Wednesday, November 30, 2022

Date:

Share:

Houston Urgent Care Offers Groundbreaking Therapy to High-Risk Patients

Related Articles

Huntington Study Group Annual Meeting

Rochester, NY, November 29, 2022 --(PR.com)-- The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its...

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Oulu, Finland, November 29, 2022 --(PR.com)-- “It is very encouraging when appreciation comes to Paras Biopharmaceuticals, especially from a USA-based company that is very innovative...

Next Level Urgent Care remains at the forefront of COVID-19 research and treatment

Press Release



updated: Aug 12, 2021


Next Level Urgent Care (NLUC) continues to offer the latest in therapeutic options for the treatment of COVID-19. After participating in the earliest research studies of the Regeneron Monoclonal Antibody Infusion, the NLUC team is now proud to offer this incredible treatment in many of their clinic locations.

The Next Level Urgent Care health providers are committed to providing the best available medical care and services for all of their patients. “We are dedicated to ensuring that our community has access to cutting-edge treatments such as the Regeneron Monoclonal Antibody Infusions,” said Next Level Urgent Care founder and CEO Juliet Breeze, MD. 

According to Breeze, the inpatient…

Read more…

Popular Articles